BRCA2 and breast carcinoma: Furthermore, despite the high frequency of BRCA2 truncating exon 11 mutations in familial breast cancer there is currently no known FA-D1 patient with biallelic truncating mutations in exon 11 (Rahman and Scott, 2007).